UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
|
||||
|
| |||
(Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Section 2 - Financial Information
Item 2.02 Results of Operations and Financial Condition.
Avery Dennison Corporation’s (the “Company’s”) press release, dated October 27, 2021, announcing the Company’s preliminary, unaudited financial results for the third quarter of 2021 and updated guidance for the 2021 fiscal year, as well as providing an update on the impact of COVID-19 on the Company, is attached hereto as Exhibit 99.1 and is being furnished (not filed) with this Form 8-K.
The Company’s supplemental presentation materials, dated October 27, 2021, regarding the Company’s preliminary, unaudited financial review and analysis for the third quarter of 2021, updated guidance for the 2021 fiscal year and update on the impact of COVID-19 on the Company, is attached hereto as Exhibit 99.2 and is being furnished (not filed) with this Form 8-K. The press release and presentation materials are also available on the Company’s website at www.investors.averydennison.com.
The Company will discuss its preliminary, unaudited financial results during a webcast and teleconference to be held on October 27, 2021, at 1:00 p.m. ET. To access the webcast and teleconference, please go to the Company’s website at www.investors.averydennison.com.
Section 9 - Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995
Certain statements contained in this Form 8-K and the exhibits attached hereto are forward-looking statements intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements, and financial or other business targets, are subject to certain risks and uncertainties. Forward-looking statements also include those related to the acquisition of Vestcom, including its anticipated benefits, financing and effect on the Company’s long-term targets and future financial results.
The Company believes that the most significant risk factors that could affect its financial performance in the near-term include: (i) the impacts to underlying demand for the Company’s products and/or foreign currency fluctuations from global economic conditions, political uncertainty, changes in environmental standards and governmental regulations, including as a result of COVID-19; (ii) competitors’ actions, including pricing, expansion in key markets, and product offerings; (iii) the degree to which higher costs can be offset with productivity measures and/or passed on to customers through price increases, without a significant loss of volume; and (iv) the execution and integration of acquisitions, including the acquisition of Vestcom.
Actual results and trends may differ materially from historical or anticipated results depending on a variety of factors, including but are not limited to, risks and uncertainties relating to the following:
● | COVID-19 |
● | International Operations – worldwide and local economic and market conditions; changes in political conditions; and fluctuations in foreign currency exchange rates and other risks associated with foreign operations, including in emerging markets |
● | The Company’s Business – changes in the Company’s markets due to competitive conditions, technological developments, environmental standards, laws and regulations, and customer preferences; fluctuations in demand affecting sales to customers; execution and integration of acquisitions, including the acquisition of Vestcom; selling prices; fluctuations in the cost and availability of raw materials and energy; the impact of competitive products and pricing; customer and supplier concentrations or consolidations; financial condition of distributors; outsourced manufacturers; product and service quality; timely development and market acceptance of new products, including sustainable or sustainably-sourced products; investment in development activities and new production facilities; successful implementation of new manufacturing technologies and installation of manufacturing equipment; the Company’s ability to generate sustained productivity improvement; the Company’s ability to achieve and sustain targeted cost reductions; and collection of receivables from customers |
● | The Vestcom acquisition – significant transaction costs or unknown or inestimable liabilities; risks related to future opportunities and plans for the combined company, including the uncertainty of expected future financial performance and results of the combined company; and the possibility that, if the Company does not achieve the perceived benefits of the acquisition as rapidly or to the extent anticipated by financial analysts or investors, the market price of the Company’s common stock could decline |
● | Income Taxes – fluctuations in tax rates; changes in tax laws and regulations, and uncertainties associated with interpretations of such laws and regulations; retention of tax incentives; outcome of tax audits; and the realization of deferred tax assets |
● | Information Technology – disruptions in information technology systems, including cyber-attacks or other intrusions to network security; successful installation of new or upgraded information technology systems; and data security breaches |
● | Human Capital – recruitment and retention of employees; fluctuations in employee benefit costs; and collective labor arrangements |
● | The Company’s Indebtedness – credit risks; the Company’s ability to obtain adequate financing arrangements and maintain access to capital; volatility of financial markets; fluctuations in interest rates; and compliance with the Company’s debt covenants |
● | Ownership of the Company’s Stock – potential significant variability of the Company’s stock price and amounts of future dividends and share repurchases |
● | Legal and Regulatory Matters – protection and infringement of intellectual property and impact of legal and regulatory proceedings, including with respect to environmental, health and safety, anti-corruption and trade compliance |
● | Other Financial Matters – fluctuations in pension costs and goodwill impairment |
For a more detailed discussion of the more significant of these factors, see Part I, Item 1A. “Risk Factors” and Part II, Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in the Company’s 2020 Form 10-K, filed with the Securities and Exchange Commission on February 25, 2021, and subsequent quarterly reports on Form 10-Q. The forward-looking statements included in this Form 8-K are made only as of the date of this Form 8-K, and the Company undertakes no obligation to update these statements to reflect subsequent events or circumstances, other than as may be required by law.
EXHIBIT INDEX
Exhibit No. |
Description | |
99.1 | Press release, dated October 27, 2021, announcing the Company’s preliminary, unaudited financial results for the third quarter of 2021. | |
99.2 | Supplemental presentation materials, dated October 27, 2021, regarding the Company’s preliminary, unaudited financial review and analysis for the third quarter of 2021. | |
104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
AVERY DENNISON CORPORATION | ||||||||||
Date: October 27, 2021 |
|
By: |
/s/ Gregory S. Lovins | |||||||
Name: |
Gregory S. Lovins | |||||||||
Title: |
Senior Vice President and Chief Financial Officer |
Exhibit 99.1
For Immediate Release
AVERY DENNISON ANNOUNCES
THIRD QUARTER 2021 RESULTS
Highlights:
● | 3Q21 Reported EPS of $1.96, up 9% |
¡ | Adjusted EPS (non-GAAP) of $2.14, up 12% |
● | 3Q21 Net sales increased 19.8% to $2.07 billion |
¡ | Sales growth ex. currency (non-GAAP) of 17.0% |
¡ | Organic sales growth (non-GAAP) of 13.9% |
● | FY 2021 EPS guidance ranges revised |
¡ | Reported EPS range now $8.55 to $8.70 (previously $8.50 to $8.80) |
¡ | Adjusted EPS range raised to $8.80 to $8.95 (previously $8.65 to $8.95) |
GLENDALE, Calif., October 27, 2021 Avery Dennison Corporation (NYSE:AVY) today announced preliminary, unaudited results for its third quarter ended October 2, 2021. Non-GAAP financial measures referenced in this document are reconciled to GAAP in the attached tables. Unless otherwise indicated, comparisons are to the same period in the prior year.
We delivered another strong quarter, said Mitch Butier, chairman, president and CEO. Both LGM and RBIS delivered impressive top and bottom-line growth, with continued momentum in Intelligent Labels. This strong performance comes during a challenging period given the ongoing global health crisis, as supply chains remain tight and significant inflationary pressures continue to build.
Given our performance in the third quarter, we raised our outlook for the full year as we continue to deliver significant earnings growth, added Butier. We are also pleased that the acquisition of Vestcom, a business that further expands our position in high value categories in RBIS and has the potential to further advance our Intelligent Labels strategy, closed in the quarter.
Once again, I want to thank our entire team for their tireless efforts to keep one another safe while delivering for all our stakeholders.
Operational/Market Update
In the third quarter, uncertainty surrounding the global health crisis remained elevated as parts of the world experienced a surge in COVID-19 cases, particularly in South Asia. As the pandemic evolves, the company has continued to adapt its world-class safety protocols. The safety and well-being of employees remains the companys top priority. The greatest impact of the increase in COVID-19 cases to the company was in Vietnam, particularly in RBIS, which was significantly constrained for the majority of the quarter. While certain manufacturing sites were operating well below full capacity, the company leveraged its global scale to minimize disruptions to customers. All manufacturing locations are now largely operational.
The company continues to actively manage through a dynamic supply and demand environment. Demand across the majority of businesses and regions remains very strong, while raw materials, freight and labor availability continue to be constrained. The company continues to leverage its global scale and work closely with customers and suppliers to minimize disruptions. Inflation remains persistent and additional pricing and material re-engineering actions are being implemented to offset higher costs.
Third Quarter 2021 Results by Segment
Label and Graphic Materials
● | Reported sales increased 18% to $1.3 billion. Compared to prior year, sales were up 15% ex. currency (12% vs. 2019) and 14% on an organic basis (11% vs. 2019). |
¡ | Label and Packaging Materials sales were up approximately 15% from prior year on an organic basis, with strong growth in both the high value product categories and the base business. |
¡ | Sales increased by approximately 11% organically in the combined Graphics and Reflective Solutions businesses. |
¡ | On an organic basis, sales were up low-double digits in North America and emerging markets and more than 20% in Western Europe. |
● | Reported operating margin decreased 140 basis points to 13.7%. Adjusted operating margin decreased 140 basis points to 13.8%, driven by the benefit of higher volume/mix, net of supply chain disruptions, which was more than offset by the net impact of pricing and raw material costs and higher employee-related costs. |
Retail Branding and Information Solutions
● | Reported sales increased 25% to $531 million. Compared to prior year, sales were up 22% ex. currency (29% vs. 2019) and 14% on an organic basis (9% vs. 2019), reflecting strong growth in both the high value product categories and the base business. |
¡ | Intelligent Labels was up approximately 15% organically (40% vs. 2019). |
● | Reported operating margin was flat to prior year at 11.0%. Adjusted operating margin increased 170 basis points to 13.8% as the benefits from higher volume and productivity were partially offset by the headwind from prior year temporary cost reduction actions, higher employee-related costs and growth investments. |
● | The Vestcom acquisition closed on August 31, 2021. Vestcom expands RBIS role managing variable data in adjacent markets and accelerates the portfolio shift to high value product categories. The Vestcom business has above average sales growth and margins; we expect modest EPS accretion from the acquisition in fiscal year 2021. |
Industrial and Healthcare Materials
● | Reported sales increased 24% to $195 million. Compared to prior year, sales were up 20% ex. currency (11% vs. 2019) and 15% on an organic basis (6% vs. 2019), reflecting a high-teens increase in industrial categories and a high-single digit increase in healthcare categories. |
● | Reported operating margin increased 170 basis points to 9.6%. Adjusted operating margin decreased 220 basis points to 9.9% as the benefit from higher volume/mix net of supply chain disruptions was more than offset by the net impact of pricing, freight and raw material costs and higher employee-related costs. |
Other
Financing, Balance Sheet and Capital Deployment
In August, the company issued $300 million of 0.850% Senior Notes due 2024 and $500 million of 2.250% Senior Notes due 2032. The company used the net proceeds from these offerings, together with cash on hand and commercial paper issuances, to finance the previously announced Vestcom acquisition that closed on August 31, 2021.
During the first three quarters of the year, the company deployed $1.5 billion for acquisitions and returned $290 million in cash to shareholders through a combination of share repurchases and dividends, up from $197 million for the same period last year. The company repurchased 0.7 million shares at an aggregate cost of $126 million. Net of dilution from long-term incentive awards, the companys share count at the end of the quarter was down by 0.3 million compared to the same time last year.
The companys balance sheet remains strong, with ample capacity to continue executing our long term capital allocation strategy. Net debt to adjusted EBITDA (non-GAAP) was 2.3 at the end of the third quarter, at the lower end of the companys long-term target range.
Income Taxes
The companys third quarter effective tax rate was 26.4%. The adjusted (non-GAAP) tax rate for the quarter was 25.3%, which is also the companys current expectation for its full year adjusted tax rate.
Cost Reduction Actions
In the third quarter, the company realized approximately $11 million in pre-tax savings from restructuring, net of transition costs, and incurred pre-tax restructuring charges of approximately $2 million.
Outlook
In its supplemental presentation materials, Third Quarter 2021 Financial Review and Analysis, the company provides a list of factors that it believes will contribute to its 2021 financial results. Based on the factors listed and other assumptions, the company has revised its guidance range for 2021 reported earnings per share from $8.50 to $8.80 to $8.55 to $8.70. Excluding an estimated $0.25 per share related to restructuring charges and other items, the companys guidance range for adjusted earnings per share has been raised from $8.65 to $8.95 to $8.80 to $8.95.
For more details on the companys results, see the summary tables accompanying this news release, as well as the supplemental presentation materials, Third Quarter 2021 Financial Review and Analysis, posted on the companys website at www.investors.averydennison.com, and furnished to the SEC on Form 8-K.
Throughout this release and the supplemental presentation materials, amounts on a per share basis reflect fully diluted shares outstanding.
About Avery Dennison
Avery Dennison Corporation (NYSE: AVY) is a global materials science company specializing in the design and manufacture of a wide variety of labeling and functional materials. The companys products, which are used in nearly every major industry, include pressure-sensitive materials for labels and graphic applications; tapes and other bonding solutions for industrial, medical, and retail applications; tags, labels and embellishments for apparel; and radio frequency identification (RFID) solutions serving retail apparel and other markets. Headquartered in Glendale, California, the company employed more than 32,000 employees in more than 50 countries in 2020. Reported sales in 2020 were $7.0 billion. Learn more at www.averydennison.com.
# # #
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
Certain statements contained in this document are forward-looking statements intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements, and financial or other business targets, are subject to certain risks and uncertainties. Forward-looking statements also include those related to the acquisition of Vestcom, including its anticipated benefits, financing and effect on our long-term targets and future financial results.
We believe that the most significant risk factors that could affect our financial performance in the near-term include: (i) the impacts to underlying demand for our products and/or foreign currency fluctuations from global economic conditions, political uncertainty, changes in environmental standards and governmental regulations, including as a result of COVID-19; (ii) competitors actions, including pricing, expansion in key markets, and product offerings; (iii) the degree to which higher costs can be offset with productivity measures and/or passed on to customers through price increases, without a significant loss of volume; and (iv) the execution and integration of acquisitions, including the acquisition of Vestcom.
Actual results and trends may differ materially from historical or anticipated results depending on a variety of factors, including but are not limited to, risks and uncertainties relating to the following:
● | COVID-19 |
● | International Operations worldwide and local economic and market conditions; changes in political conditions; and fluctuations in foreign currency exchange rates and other risks associated with foreign operations, including in emerging markets |
● | Our Business changes in our markets due to competitive conditions, technological developments, environmental standards, laws and regulations, and customer preferences; fluctuations in demand affecting sales to customers; execution and integration of acquisitions, including the acquisition of Vestcom; selling prices; fluctuations in the cost and availability of raw materials and energy; the impact of competitive products and pricing; customer and supplier concentrations or consolidations; financial condition of distributors; outsourced manufacturers; product and service quality; timely development and market acceptance of new products, including sustainable or sustainably-sourced products; investment in development activities and new production facilities; successful implementation of new manufacturing technologies and installation of manufacturing equipment; our ability to generate sustained productivity improvement; our ability to achieve and sustain targeted cost reductions; and collection of receivables from customers |
● | Vestcom acquisition significant transaction costs or unknown or inestimable liabilities; risks related to future opportunities and plans for the combined company, including the uncertainty of expected future financial performance and results of the combined company; and the possibility that, if we do not achieve the perceived benefits of the acquisition as rapidly or to the extent anticipated by financial analysts or investors, the market price of our common stock could decline |
● | Income Taxes fluctuations in tax rates; changes in tax laws and regulations, and uncertainties associated with interpretations of such laws and regulations; retention of tax incentives; outcome of tax audits; and the realization of deferred tax assets |
● | Information Technology disruptions in information technology systems, including cyber-attacks or other intrusions to network security; successful installation of new or upgraded information technology systems; and data security breaches |
● | Human Capital recruitment and retention of employees; fluctuations in employee benefit costs; and collective labor arrangements |
● | Our Indebtedness credit risks; our ability to obtain adequate financing arrangements and maintain access to capital; volatility of financial markets; fluctuations in interest rates; and compliance with our debt covenants |
● | Ownership of Our Stock potential significant variability of our stock price and amounts of future dividends and share repurchases |
● | Legal and Regulatory Matters protection and infringement of intellectual property and impact of legal and regulatory proceedings, including with respect to environmental, health and safety, anti-corruption and trade compliance |
● | Other Financial Matters fluctuations in pension costs and goodwill impairment |
For a more detailed discussion of these factors, see Risk Factors and Managements Discussion and Analysis of Financial Condition and Results of Operations in our 2020 Form 10-K, filed with the Securities and Exchange Commission on February 25, 2021, and subsequent quarterly reports on Form 10-Q.
The forward-looking statements included in this document are made only as of the date of this document, and we undertake no obligation to update these statements to reflect subsequent events or circumstances, other than as may be required by law.
For more information and to listen to a live broadcast or an audio replay of the quarterly conference call with analysts, visit the Avery Dennison website at www.investors.averydennison.com
Contacts:
Media Relations:
Rob Six (626) 304-2361
rob.six@averydennison.com
Investor Relations:
John Eble (440) 534-6290
john.eble@averydennison.com
Third Quarter Financial Summary - Preliminary, unaudited |
|
|||||||||||||||||||||||||||||||||||||||||||||||
(In millions, except % and per share amounts) |
|
|||||||||||||||||||||||||||||||||||||||||||||||
3Q | 3Q | % Sales Change vs. P/Y | ||||||||||||||||||||||||||||||||||||||||||||||
2021 | 2020 | Reported | Ex. Currency | Organic | ||||||||||||||||||||||||||||||||||||||||||||
(a) | (b) | |||||||||||||||||||||||||||||||||||||||||||||||
Net sales, by segment: |
||||||||||||||||||||||||||||||||||||||||||||||||
Label and Graphic Materials |
$1,345.8 | $1,145.4 | 17.5% | 14.6% | 14.0% | |||||||||||||||||||||||||||||||||||||||||||
Retail Branding and Information Solutions |
530.7 | 426.1 | 24.5% | 22.2% | 13.5% | |||||||||||||||||||||||||||||||||||||||||||
Industrial and Healthcare Materials |
195.3 | 157.6 | 23.9% | 20.0% | 14.9% | |||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||||||
Total net sales |
$2,071.8 | $1,729.1 | 19.8% | 17.0% | 13.9% | |||||||||||||||||||||||||||||||||||||||||||
As Reported (GAAP) | Adjusted Non-GAAP (c) | |||||||||||||||||||||||||||||||||||||||||||||||
3Q | 3Q | % | % of Sales | 3Q | 3Q | % | % of Sales | |||||||||||||||||||||||||||||||||||||||||
2021 | 2020 | Change | 2021 | 2020 | 2021 | 2020 | Change | 2021 | 2020 | |||||||||||||||||||||||||||||||||||||||
Operating income (loss) / operating margins before interest, other non-operating expense (income), and taxes, by segment: |
||||||||||||||||||||||||||||||||||||||||||||||||
Label and Graphic Materials |
$184.9 | $173.1 | 13.7% | 15.1% | $185.1 | $174.5 | 13.8% | 15.2% | ||||||||||||||||||||||||||||||||||||||||
Retail Branding and Information Solutions |
58.5 | 47.0 | 11.0% | 11.0% | 73.1 | 51.4 | 13.8% | 12.1% | ||||||||||||||||||||||||||||||||||||||||
Industrial and Healthcare Materials |
18.7 | 12.5 | 9.6% | 7.9% | 19.4 | 19.1 | 9.9% | 12.1% | ||||||||||||||||||||||||||||||||||||||||
Corporate expense (d) |
(20.6) | (19.1) | (20.1) | (19.1) | ||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
Total operating income / operating margins before interest, other non-operating expense (income), and taxes |
$241.5 | $213.5 | 13% | 11.7% | 12.3% | $257.5 | $225.9 | 14% | 12.4% | 13.1% | ||||||||||||||||||||||||||||||||||||||
Interest expense |
$18.0 | $15.6 | $18.0 | $15.6 | ||||||||||||||||||||||||||||||||||||||||||||
Other non-operating expense (income), net (e) |
($0.9) | $0.1 | ($1.5) | $0.1 | ||||||||||||||||||||||||||||||||||||||||||||
Income before taxes |
$224.4 | $197.8 | 13% | 10.8% | 11.4% | $241.0 | $210.2 | 15% | 11.6% | 12.2% | ||||||||||||||||||||||||||||||||||||||
Provision for (benefit from) income taxes |
$59.2 | $46.3 | $61.0 | $48.7 | ||||||||||||||||||||||||||||||||||||||||||||
Equity method investment (losses) gains |
($1.1) | ($1.0) | ($1.1) | ($1.0) | ||||||||||||||||||||||||||||||||||||||||||||
Net income |
$164.1 | $150.5 | 9% | 7.9% | 8.7% | $178.9 | $160.5 | 11% | 8.6% | 9.3% | ||||||||||||||||||||||||||||||||||||||
Net income per common share, assuming dilution |
$1.96 | $1.79 | 9% | $2.14 | $1.91 | 12% | ||||||||||||||||||||||||||||||||||||||||||
3Q Free Cash Flow (f) |
$251.2 | $232.9 | ||||||||||||||||||||||||||||||||||||||||||||||
YTD Free Cash Flow (f) |
$639.2 | $341.7 |
See accompanying schedules A-4 to A-10 for reconciliations from GAAP to non-GAAP financial measures.
(a) | Sales change ex. currency refers to the increase or decrease in net sales, excluding the estimated impact of foreign currency translation, and, where applicable, the calendar shift resulting from the extra week in the prior fiscal year and currency adjustment for transitional reporting of highly inflationary economies. The estimated impact of foreign currency translation is calculated on a constant currency basis, with prior period results translated at current period average exchange rates to exclude the effect of currency fluctuations. |
(b) | Organic sales change refers to sales change ex. currency, excluding the estimated impact of acquisitions and product line divestitures. |
(c) | Excludes impact of restructuring charges and other items. |
(d) | As reported Corporate expense in the third quarter of 2021 includes severance and related costs of $.5. |
(e) | As reported Other non-operating expense (income), net in the third quarter of 2021 includes pension plan settlement loss of $.6. |
(f) | Free cash flow refers to cash flow provided by operating activities, less payments for property, plant and equipment, software and other deferred charges, plus proceeds from sales of property, plant and equipment, plus (minus) net proceeds from insurance and sales (purchases) of investments. Free cash flow is also adjusted for, where applicable, certain acquisition-related transaction costs. |
A-1
AVERY DENNISON CORPORATION
PRELIMINARY CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(In millions, except per share amounts)
(UNAUDITED) | ||||||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||||||
Oct. 2, 2021 | Sep. 26, 2020 | Oct. 2, 2021 | Sep. 26, 2020 | |||||||||||||||||
Net sales |
$ 2,071.8 | $ 1,729.1 | $ 6,225.1 | $ 4,980.6 | ||||||||||||||||
Cost of products sold |
1,517.4 | 1,244.9 | 4,497.4 | 3,628.4 | ||||||||||||||||
Gross profit |
554.4 | 484.2 | 1,727.7 | 1,352.2 | ||||||||||||||||
Marketing, general and administrative expense |
296.9 | 258.3 | 916.2 | 758.7 | ||||||||||||||||
Other expense (income), net(1) |
16.0 | 12.4 | 16.3 | 57.3 | ||||||||||||||||
Interest expense |
18.0 | 15.6 | 50.2 | 54.4 | ||||||||||||||||
Other non-operating expense (income), net(2) |
(0.9 | ) | 0.1 | (3.6 | ) | (0.2 | ) | |||||||||||||
Income before taxes |
224.4 | 197.8 | 748.6 | 482.0 | ||||||||||||||||
Provision for (benefit from) income taxes |
59.2 | 46.3 | 187.7 | 114.8 | ||||||||||||||||
Equity method investment (losses) gains |
(1.1 | ) | (1.0 | ) | (3.5 | ) | (2.8 | ) | ||||||||||||
Net income |
$ 164.1 | $ 150.5 | $ 557.4 | $ 364.4 | ||||||||||||||||
Per share amounts: |
||||||||||||||||||||
Net income per common share, assuming dilution |
$ 1.96 | $ 1.79 | $ 6.64 | $ 4.34 | ||||||||||||||||
Weighted average number of common shares outstanding, assuming dilution |
83.7 | 84.0 | 83.9 | 84.0 |
(1) | Other expense (income), net for the third quarter of 2021 includes severance and related costs of $1.1, asset impairment charges of $1.3 and transaction and related costs of $19.4, partially offset by gain on investment of $4.9 and gain on sale of product line of $.9. |
Other expense (income), net for the third quarter of 2020 includes severance and related costs of $6.5, asset impairment charges of $4.4, and loss on investment of $1.5.
Other expense (income), net for 2021 YTD includes severance and related costs of $5.1, asset impairment and lease cancellation charges of $1.9, transaction and related costs of $20.1, and loss on sale of assets, net, of $.2, partially offset by gain on sale of product line of $5.7, gain on investment of $4.9, and outcomes of legal proceedings, net, of $.4.
Other expense (income), net for 2020 YTD includes severance and related costs of $46.4, asset impairment charges of $6.2, transaction and related costs of $3.2, and loss on investment of $1.5.
(2) | Other non-operating expense (income), net for 2021 QTD and YTD includes pension plan settlement loss of $.6 and $1, respectively. |
-more-
A-2
AVERY DENNISON CORPORATION
PRELIMINARY CONDENSED CONSOLIDATED BALANCE SHEETS
(In millions)
(UNAUDITED) | ||||||||
ASSETS | Oct. 2, 2021 | Sep. 26, 2020 | ||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ | 207.2 | $ | 284.7 | ||||
Trade accounts receivable, net |
1,441.2 | 1,212.7 | ||||||
Inventories, net |
879.1 | 662.6 | ||||||
Other current assets |
251.0 | 214.5 | ||||||
Total current assets |
2,778.5 | 2,374.5 | ||||||
Property, plant and equipment, net |
1,405.5 | 1,233.9 | ||||||
Goodwill and other intangibles resulting from business acquisitions, net |
2,828.2 | 1,253.4 | ||||||
Deferred tax assets |
152.7 | 203.3 | ||||||
Other assets |
802.8 | 655.7 | ||||||
$ | 7,967.7 | $ | 5,720.8 | |||||
LIABILITIES AND SHAREHOLDERS EQUITY |
||||||||
Current liabilities: |
||||||||
Short-term borrowings and current portion of long-term debt and finance leases |
$ | 398.8 | $ | 124.1 | ||||
Accounts payable |
1,268.2 | 932.8 | ||||||
Other current liabilities |
942.4 | 759.1 | ||||||
Total current liabilities |
2,609.4 | 1,816.0 | ||||||
Long-term debt and finance leases |
2,800.2 | 2,020.0 | ||||||
Other long-term liabilities |
758.9 | 550.2 | ||||||
Shareholders equity: |
||||||||
Common stock |
124.1 | 124.1 | ||||||
Capital in excess of par value |
854.8 | 850.3 | ||||||
Retained earnings |
3,749.7 | 3,205.5 | ||||||
Treasury stock at cost |
(2,606.4 | ) | (2,451.4 | ) | ||||
Accumulated other comprehensive loss |
(323.0 | ) | (393.9 | ) | ||||
Total shareholders equity |
1,799.2 | 1,334.6 | ||||||
$ | 7,967.7 | $ | 5,720.8 |
-more-
A-3
AVERY DENNISON CORPORATION
PRELIMINARY CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In millions)
(UNAUDITED) | ||||||||||||
Nine Months Ended | ||||||||||||
Oct. 2, 2021 | Sep. 26, 2020 | |||||||||||
Operating Activities: |
|
|||||||||||
Net income |
$ | 557.4 | $ | 364.4 | ||||||||
Adjustments to reconcile net income to net cash provided by operating activities: |
||||||||||||
Depreciation |
122.9 | 113.7 | ||||||||||
Amortization |
48.6 | 36.1 | ||||||||||
Provision for credit losses and sales returns |
26.1 | 50.4 | ||||||||||
Stock-based compensation |
27.1 | 12.1 | ||||||||||
Pension plan settlement loss |
1.0 | --- | ||||||||||
Deferred taxes and other non-cash taxes |
(1.5 | ) | 17.1 | |||||||||
Other non-cash expense and loss (income and gain), net |
17.7 | 35.3 | ||||||||||
Changes in assets and liabilities and other adjustments |
(36.5 | ) | (187.3 | ) | ||||||||
Net cash provided by operating activities |
762.8 | 441.8 | ||||||||||
Investing Activities: |
||||||||||||
Purchases of property, plant and equipment |
(130.6 | ) | (91.7 | ) | ||||||||
Purchases of software and other deferred charges |
(9.8 | ) | (13.8 | ) | ||||||||
Proceeds from sales of property, plant and equipment |
1.1 | 0.2 | ||||||||||
Proceeds from insurance and sales (purchases) of investments, net |
1.2 | 5.2 | ||||||||||
Proceeds from sale of product line |
6.7 | --- | ||||||||||
Payments for acquisitions, net of cash acquired, and investments in businesses |
(1,474.3 | ) | (262.8 | ) | ||||||||
Net cash used in investing activities |
(1,605.7 | ) | (362.9 | ) | ||||||||
Financing Activities: |
||||||||||||
Net increase (decrease) in borrowings with maturities of three months or less |
332.0 | (57.1 | ) | |||||||||
Additional borrowings under revolving credit facility |
--- | 500.0 | ||||||||||
Repayments of revolving credit facility |
--- | (500.0 | ) | |||||||||
Additional long-term borrowings |
791.9 | 493.7 | ||||||||||
Repayments of long-term debt and finance leases |
(8.0 | ) | (268.9 | ) | ||||||||
Dividends paid |
(164.3 | ) | (145.2 | ) | ||||||||
Share repurchases |
(126.0 | ) | (52.2 | ) | ||||||||
Net (tax withholding) proceeds related to stock-based compensation |
(25.5 | ) | (20.0 | ) | ||||||||
Net cash provided by (used in) financing activities |
800.1 | (49.7 | ) | |||||||||
Effect of foreign currency translation on cash balances |
(2.3 | ) | 1.8 | |||||||||
Increase (decrease) in cash and cash equivalents |
(45.1 | ) | 31.0 | |||||||||
Cash and cash equivalents, beginning of year |
252.3 | 253.7 | ||||||||||
Cash and cash equivalents, end of period |
$ | 207.2 | $ | 284.7 |
-more-
A-4
Reconciliation of Non-GAAP Financial Measures to GAAP
We report our financial results in conformity with accounting principles generally accepted in the United States of America, or GAAP, and also communicate with investors using certain non-GAAP financial measures. These non-GAAP financial measures are not in accordance with, nor are they a substitute for or superior to, the comparable GAAP financial measures. These non-GAAP financial measures are intended to supplement the presentation of our financial results that are prepared in accordance with GAAP. Based upon feedback from investors and financial analysts, we believe that the supplemental non-GAAP financial measures we provide are useful to their assessments of our performance and operating trends, as well as liquidity.
Our non-GAAP financial measures exclude the impact of certain events, activities or strategic decisions. The accounting effects of these events, activities or decisions, which are included in the GAAP financial measures, may make it difficult to assess our underlying performance in a single period. By excluding the accounting effects, positive or negative, of certain items (e.g., restructuring charges, outcomes of certain legal proceedings, certain effects of strategic transactions and related costs, losses from debt extinguishments, gains or losses from curtailment or settlement of pension obligations, gains or losses on sales of certain assets, gains or losses on investments, and other items), we believe that we are providing meaningful supplemental information that facilitates an understanding of our core operating results and liquidity measures. While some of the items we exclude from GAAP financial measures recur, they tend to be disparate in amount, frequency, or timing.
We use these non-GAAP financial measures internally to evaluate trends in our underlying performance, as well as to facilitate comparison to the results of competitors for quarters and year-to-date periods, as applicable.
We use the non-GAAP financial measures described below in the accompanying news release and presentation.
Sales change ex. currency refers to the increase or decrease in net sales, excluding the estimated impact of foreign currency translation, and, where applicable, the calendar shift resulting from the extra week in the prior fiscal year and currency adjustment for transitional reporting of highly inflationary economies. The estimated impact of foreign currency translation is calculated on a constant currency basis, with prior period results translated at current period average exchange rates to exclude the effect of currency fluctuations.
Organic sales change refers to sales change ex. currency, excluding the estimated impact of acquisitions and product line divestitures.
We believe that sales change ex. currency and organic sales change assist investors in evaluating the sales change from the ongoing activities of our businesses and enhance their ability to evaluate our results from period to period.
Adjusted operating income refers to income before taxes; interest expense; other non-operating expense (income), net; and other expense (income), net.
Adjusted EBITDA refers to adjusted operating income before depreciation and amortization.
Adjusted operating margin refers to adjusted operating income as a percentage of net sales.
Adjusted EBITDA margin refers to adjusted EBITDA as a percentage of net sales.
Adjusted tax rate refers to the projected full-year GAAP tax rate, adjusted to exclude certain unusual or infrequent events that are expected to significantly impact that rate, such as effects of certain discrete tax planning actions, impacts related to the enactment of the U.S. Tax Cuts and Jobs Act (TCJA), where applicable, and other items.
Adjusted net income refers to income before taxes, tax-effected at the adjusted tax rate, and adjusted for tax-effected restructuring charges and other items.
Adjusted net income per common share, assuming dilution (adjusted EPS) refers to adjusted net income divided by the weighted average number of common shares outstanding, assuming dilution.
We believe that adjusted operating margin, adjusted EBITDA margin, adjusted net income, and adjusted EPS assist investors in understanding our core operating trends and comparing our results with those of our competitors.
Net debt to adjusted EBITDA ratio refers to total debt (including finance leases) less cash and cash equivalents, divided by adjusted EBITDA for the last twelve months. We believe that the net debt to adjusted EBITDA ratio assists investors in assessing our leverage position.
Free cash flow refers to cash flow provided by operating activities, less payments for property, plant and equipment, software and other deferred charges, plus proceeds from sales of property, plant and equipment, plus (minus) net proceeds from insurance and sales (purchases) of investments. Free cash flow is also adjusted for, where applicable, certain acquisition-related transaction costs. We believe that free cash flow assists investors by showing the amount of cash we have available for debt reductions, dividends, share repurchases, and acquisitions.
Reconciliations are provided in accordance with Regulations G and S-K and reconcile our non-GAAP financial measures with the most directly comparable GAAP financial measures.
-more-
A-5
AVERY DENNISON CORPORATION
PRELIMINARY RECONCILIATION FROM GAAP TO NON-GAAP FINANCIAL MEASURES
(In millions, except % and per share amounts)
(UNAUDITED) | ||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
Oct. 2, 2021 | Sep. 26, 2020 | Oct. 2, 2021 | Sep. 26, 2020 | |||||||||||||
Reconciliation from GAAP to Non-GAAP operating margins: |
||||||||||||||||
Net sales |
$ | 2,071.8 | $ | 1,729.1 | $ | 6,225.1 | $ | 4,980.6 | ||||||||
Income before taxes |
$ | 224.4 | $ | 197.8 | $ | 748.6 | $ | 482.0 | ||||||||
Income before taxes as a percentage of net sales |
10.8% | 11.4% | 12.0% | 9.7% | ||||||||||||
Adjustments: |
||||||||||||||||
Interest expense |
$ | 18.0 | $ | 15.6 | $ | 50.2 | $ | 54.4 | ||||||||
Other non-operating expense (income), net |
(0.9 | ) | 0.1 | (3.6 | ) | (0.2 | ) | |||||||||
Operating income before interest expense, other non-operating expense (income), and taxes |
$ | 241.5 | $ | 213.5 | $ | 795.2 | $ | 536.2 | ||||||||
Operating margins |
11.7% | 12.3% | 12.8% | 10.8% | ||||||||||||
Income before taxes |
$ | 224.4 | $ | 197.8 | $ | 748.6 | $ | 482.0 | ||||||||
Adjustments: |
||||||||||||||||
Restructuring charges: |
||||||||||||||||
Severance and related costs |
1.1 | 6.5 | 5.1 | 46.4 | ||||||||||||
Asset impairment and lease cancellation charges |
1.3 | 4.4 | 1.9 | 6.2 | ||||||||||||
Transaction and related costs |
19.4 | --- | 20.1 | 3.2 | ||||||||||||
Loss on sale of assets, net |
--- | --- | 0.2 | --- | ||||||||||||
(Gain) loss on investments |
(4.9 | ) | 1.5 | (4.9 | ) | 1.5 | ||||||||||
Gain on sale of product line |
(0.9 | ) | --- | (5.7 | ) | --- | ||||||||||
Outcomes of legal proceedings, net(1) |
--- | --- | (0.4 | ) | --- | |||||||||||
Interest expense |
18.0 | 15.6 | 50.2 | 54.4 | ||||||||||||
Other non-operating expense (income), net |
(0.9 | ) | 0.1 | (3.6 | ) | (0.2 | ) | |||||||||
Adjusted operating income (non-GAAP) |
$ | 257.5 | $ | 225.9 | $ | 811.5 | $ | 593.5 | ||||||||
Adjusted operating margins (non-GAAP) |
12.4% | 13.1% | 13.0% | 11.9% | ||||||||||||
Reconciliation from GAAP to Non-GAAP net income: |
||||||||||||||||
As reported net income |
$ | 164.1 | $ | 150.5 | $ | 557.4 | $ | 364.4 | ||||||||
Adjustments: |
||||||||||||||||
Restructuring charges and other items(2) |
16.0 | 12.4 | 16.3 | 57.3 | ||||||||||||
Pension plan settlement loss |
0.6 | --- | 1.0 | --- | ||||||||||||
Tax effect on restructuring charges and other items and impact of adjusted tax rate |
(1.8 | ) | (2.4 | ) | (6.1 | ) | (15.2 | ) | ||||||||
Adjusted net income (non-GAAP) |
$ | 178.9 | $ | 160.5 | $ | 568.6 | $ | 406.5 |
(1) | 2021 YTD includes Brazil indirect tax credit based on the Brazilian Federal Supreme Court ruling of $29.1, partially offset by contingent liability related to patent infringement jury verdict of $26.6 and legal settlement of $2.1. |
(2) | Includes pretax restructuring and related charges, transaction and related costs, loss on sale of assets, gain/loss on investments, gain on sale of product line, and outcomes of legal proceedings. |
-more-
A-5
(continued)
AVERY DENNISON CORPORATION
PRELIMINARY RECONCILIATION FROM GAAP TO NON-GAAP FINANCIAL MEASURES
(In millions, except % and per share amounts)
(UNAUDITED) | ||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
Oct. 2, 2021 | Sep. 26, 2020 | Oct. 2, 2021 | Sep. 26, 2020 | |||||||||||||
Reconciliation from GAAP to Non-GAAP net income per common share: |
||||||||||||||||
As reported net income per common share, assuming dilution |
$ 1.96 | $ 1.79 | $ 6.64 | $ 4.34 | ||||||||||||
Adjustments per common share, net of tax: |
||||||||||||||||
Restructuring charges and other items(1) |
0.20 | 0.15 | 0.21 | 0.68 | ||||||||||||
Tax effect on restructuring charges and other items and impact of adjusted tax rate |
(0.02 | ) | (0.03 | ) | (0.07 | ) | (0.18 | ) | ||||||||
Adjusted net income per common share, assuming dilution (non-GAAP) |
$ 2.14 | $ 1.91 | $ 6.78 | $ 4.84 | ||||||||||||
Weighted average number of common shares outstanding, assuming dilution |
83.7 | 84.0 | 83.9 | 84.0 |
Our adjusted tax rate was 25.3% for the three and nine months ended Oct. 2, 2021, and 23.2% and 24.1% for the three and nine months ended Sep. 26, 2020, respectively.
(1) | Includes pretax restructuring and related charges, transaction and related costs, loss on sale of assets, gain/loss on investments, gain on sale of product line, outcomes of legal proceedings, and pension plan settlement loss. |
(UNAUDITED) | ||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
Oct. 2, 2021 | Sep. 26, 2020 | Oct. 2, 2021 | Sep. 26, 2020 | |||||||||||||
Reconciliation of free cash flow: |
|
|||||||||||||||
Net cash provided by operating activities |
$ | 286.0 | $ | 257.8 | $ | 762.8 | $ | 441.8 | ||||||||
Purchases of property, plant and equipment |
(46.8 | ) | (27.8 | ) | (130.6 | ) | (91.7 | ) | ||||||||
Purchases of software and other deferred charges |
(3.4 | ) | (2.8 | ) | (9.8 | ) | (13.8 | ) | ||||||||
Proceeds from sales of property, plant and equipment |
0.1 | 0.1 | 1.1 | 0.2 | ||||||||||||
Proceeds from insurance and sales (purchases) of investments, net |
0.8 | 5.6 | 1.2 | 5.2 | ||||||||||||
Payments for certain acquisition-related transaction costs |
14.5 | --- | 14.5 | --- | ||||||||||||
Free cash flow (non-GAAP) |
$ | 251.2 | $ | 232.9 | $ | 639.2 | $ | 341.7 |
-more-
A-6
AVERY DENNISON CORPORATION
PRELIMINARY SUPPLEMENTARY INFORMATION
(In millions, except %)
(UNAUDITED)
Third Quarter Ended | ||||||||||||||||||||||||||||||||
NET SALES | OPERATING INCOME (LOSS) | OPERATING MARGINS | ||||||||||||||||||||||||||||||
2021 | 2020 | 2021 | 2020 | 2021 | 2020 | |||||||||||||||||||||||||||
Label and Graphic Materials |
$ | 1,345.8 | $ | 1,145.4 | $ | 184.9 | $ | 173.1 | 13.7% | 15.1% | ||||||||||||||||||||||
Retail Branding and Information Solutions |
530.7 | 426.1 | 58.5 | 47.0 | 11.0% | 11.0% | ||||||||||||||||||||||||||
Industrial and Healthcare Materials |
195.3 | 157.6 | 18.7 | 12.5 | 9.6% | 7.9% | ||||||||||||||||||||||||||
Corporate Expense |
N/A | N/A | (20.6 | ) | (19.1 | ) | N/A | N/A | ||||||||||||||||||||||||
TOTAL FROM OPERATIONS |
$ | 2,071.8 | $ | 1,729.1 | $ | 241.5 | $ | 213.5 | 11.7% | 12.3% | ||||||||||||||||||||||
RECONCILIATION FROM GAAP TO NON-GAAP SUPPLEMENTARY INFORMATION
Third Quarter Ended | ||||||||||||||||||||
OPERATING INCOME | OPERATING MARGINS | |||||||||||||||||||
2021 | 2020 | 2021 | 2020 | |||||||||||||||||
Label and Graphic Materials |
||||||||||||||||||||
Operating income and margins, as reported |
$ | 184.9 | $ | 173.1 | 13.7% | 15.1% | ||||||||||||||
Adjustments: |
||||||||||||||||||||
Restructuring charges: |
||||||||||||||||||||
Severance and related costs |
(0.4 | ) | 1.4 | --- | 0.1% | |||||||||||||||
Asset impairment charges |
1.2 | --- | 0.1% | --- | ||||||||||||||||
Transaction and related costs |
0.3 | --- | --- | --- | ||||||||||||||||
Gain on sale of product line |
(0.9 | ) | --- | --- | --- | |||||||||||||||
Adjusted operating income and margins (non-GAAP) |
$ | 185.1 | $ | 174.5 | 13.8% | 15.2% | ||||||||||||||
Depreciation and amortization |
28.8 | 26.0 | 2.1% | 2.3% | ||||||||||||||||
Adjusted EBITDA and margins (non-GAAP) |
$ | 213.9 | $ | 200.5 | 15.9% | 17.5% | ||||||||||||||
Retail Branding and Information Solutions |
||||||||||||||||||||
Operating income and margins, as reported |
$ | 58.5 | $ | 47.0 | 11.0% | 11.0% | ||||||||||||||
Adjustments: |
||||||||||||||||||||
Restructuring charges: |
||||||||||||||||||||
Severance and related costs |
0.7 | 2.2 | 0.2% | 0.5% | ||||||||||||||||
Asset impairment charges |
0.1 | 0.7 | --- | 0.2% | ||||||||||||||||
Transaction and related costs |
18.7 | --- | 3.5% | --- | ||||||||||||||||
(Gain) loss on investments |
(4.9 | ) | 1.5 | (0.9% | ) | 0.4% | ||||||||||||||
Adjusted operating income and margins (non-GAAP) |
$ | 73.1 | $ | 51.4 | 13.8% | 12.1% | ||||||||||||||
Depreciation and amortization |
26.3 | 19.0 | 4.9% | 4.4% | ||||||||||||||||
Adjusted EBITDA and margins (non-GAAP) |
$ | 99.4 | $ | 70.4 | 18.7% | 16.5% | ||||||||||||||
Industrial and Healthcare Materials |
||||||||||||||||||||
Operating income and margins, as reported |
$ | 18.7 | $ | 12.5 | 9.6% | 7.9% | ||||||||||||||
Adjustments: |
||||||||||||||||||||
Restructuring charges: |
||||||||||||||||||||
Severance and related costs |
0.3 | 2.9 | 0.1% | 1.8% | ||||||||||||||||
Asset impairment charges |
--- | 3.7 | --- | 2.4% | ||||||||||||||||
Transaction and related costs |
0.4 | --- | 0.2% | --- | ||||||||||||||||
Adjusted operating income and margins (non-GAAP) |
$ | 19.4 | $ | 19.1 | 9.9% | 12.1% | ||||||||||||||
Depreciation and amortization |
6.8 | 7.0 | 3.5% | 4.5% | ||||||||||||||||
Adjusted EBITDA and margins (non-GAAP) |
$ | 26.2 | $ | 26.1 | 13.4% | 16.6% |
-more-
A-7
AVERY DENNISON CORPORATION
PRELIMINARY SUPPLEMENTARY INFORMATION
(In millions, except %)
(UNAUDITED)
Nine Months Ended | ||||||||||||||||||||||||
NET SALES | OPERATING INCOME (LOSS) | OPERATING MARGINS | ||||||||||||||||||||||
2021 | 2020 | 2021 | 2020 | 2021 | 2020 | |||||||||||||||||||
|
|
|
|
|
|
|||||||||||||||||||
Label and Graphic Materials |
$ | 4,099.0 | $ | 3,420.4 | $ | 639.2 | $ | 483.1 | 15.6% | 14.1% | ||||||||||||||
Retail Branding and Information Solutions |
1,542.7 | 1,122.9 | 160.6 | 67.2 | 10.4% | 6.0% | ||||||||||||||||||
Industrial and Healthcare Materials |
583.4 | 437.3 | 64.7 | 34.9 | 11.1% | 8.0% | ||||||||||||||||||
Corporate Expense |
N/A | N/A | (69.3 | ) | (49.0 | ) | N/A | N/A | ||||||||||||||||
|
|
|
|
|
|
|||||||||||||||||||
TOTAL FROM OPERATIONS |
$ | 6,225.1 | $ | 4,980.6 | $ | 795.2 | $ | 536.2 | 12.8% | 10.8% | ||||||||||||||
|
|
|
|
|
|
RECONCILIATION FROM GAAP TO NON-GAAP SUPPLEMENTARY INFORMATION
Nine Months Ended | ||||||||||||||||
OPERATING INCOME | OPERATING MARGINS | |||||||||||||||
2021 | 2020 | 2021 | 2020 | |||||||||||||
|
|
|
|
|||||||||||||
Label and Graphic Materials |
||||||||||||||||
Operating income and margins, as reported |
$ | 639.2 | $ | 483.1 | 15.6% | 14.1% | ||||||||||
Adjustments: |
||||||||||||||||
Restructuring charges: |
||||||||||||||||
Severance and related costs |
0.1 | 26.7 | --- | 0.8% | ||||||||||||
Asset impairment charges |
1.3 | 0.9 | --- | 0.1% | ||||||||||||
Transaction and related costs |
0.4 | 0.7 | --- | --- | ||||||||||||
Outcomes of legal proceedings, net(1) |
(26.3 | ) | --- | (0.6% | ) | --- | ||||||||||
Gain on sale of product line |
(5.7 | ) | --- | (0.1% | ) | --- | ||||||||||
|
|
|
|
|||||||||||||
Adjusted operating income and margins (non-GAAP) |
$ | 609.0 | $ | 511.4 | 14.9% | 15.0% | ||||||||||
Depreciation and amortization |
86.5 | 78.4 | 2.1% | 2.2% | ||||||||||||
|
|
|
|
|||||||||||||
Adjusted EBITDA and margins (non-GAAP) |
$ | 695.5 | $ | 589.8 | 17.0% | 17.2% | ||||||||||
|
|
|
|
|||||||||||||
Retail Branding and Information Solutions |
||||||||||||||||
Operating income and margins, as reported |
$ | 160.6 | $ | 67.2 | 10.4% | 6.0% | ||||||||||
Adjustments: |
||||||||||||||||
Restructuring charges: |
||||||||||||||||
Severance and related costs |
3.2 | 15.0 | 0.2% | 1.4% | ||||||||||||
Asset impairment and lease cancellation charges |
0.6 | 1.6 | 0.1% | 0.1% | ||||||||||||
Transaction and related costs |
18.9 | 2.5 | 1.2% | 0.2% | ||||||||||||
Outcomes of legal proceedings, net(2) |
25.9 | --- | 1.7% | --- | ||||||||||||
Loss on sale of asset |
0.5 | --- | --- | --- | ||||||||||||
(Gain) loss on investments |
(4.9 | ) | 1.5 | (0.3% | ) | 0.1% | ||||||||||
|
|
|
|
|||||||||||||
Adjusted operating income and margins (non-GAAP) |
$ | 204.8 | $ | 87.8 | 13.3% | 7.8% | ||||||||||
Depreciation and amortization |
64.3 | 51.6 | 4.1% | 4.6% | ||||||||||||
|
|
|
|
|||||||||||||
Adjusted EBITDA and margins (non-GAAP) |
$ | 269.1 | $ | 139.4 | 17.4% | 12.4% | ||||||||||
|
|
|
|
|||||||||||||
Industrial and Healthcare Materials |
||||||||||||||||
Operating income and margins, as reported |
$ | 64.7 | $ | 34.9 | 11.1% | 8.0% | ||||||||||
Adjustments: |
||||||||||||||||
Restructuring charges: |
||||||||||||||||
Severance and related costs |
0.8 | 4.9 | 0.1% | 1.1% | ||||||||||||
Asset impairment charges |
--- | 3.7 | --- | 0.8% | ||||||||||||
Transaction and related costs |
0.8 | --- | 0.1% | --- | ||||||||||||
Gain on sale of assets |
(0.3 | ) | --- | --- | --- | |||||||||||
|
|
|
|
|||||||||||||
Adjusted operating income and margins (non-GAAP) |
$ | 66.0 | $ | 43.5 | 11.3% | 9.9% | ||||||||||
Depreciation and amortization |
20.7 | 19.8 | 3.6% | 4.6% | ||||||||||||
|
|
|
|
|||||||||||||
Adjusted EBITDA and margins (non-GAAP) |
$ | 86.7 | $ | 63.3 | 14.9% | 14.5% | ||||||||||
|
|
|
|
(1) | 2021 YTD includes Brazil indirect tax credit based on the Brazilian Federal Supreme Court ruling of $28.4, partially offset by legal settlement of $2.1. |
(2) | 2021 YTD includes contingent liability related to patent infringement jury verdict of $26.6, partially offset by Brazil indirect tax credit based on the Brazilian Federal Supreme Court ruling of $.7. |
-more-
A-8
AVERY DENNISON CORPORATION
PRELIMINARY SUPPLEMENTARY INFORMATION
Reconciliation of Adjusted EBITDA Margins
(In millions, except %)
(UNAUDITED)
(13 weeks) | (13 weeks) | (13 weeks) | ||||||||||
Label and Graphic Materials | 3Q21 | 3Q20 | 3Q19 | |||||||||
Net sales |
$ | 1,345.8 | $ | 1,145.4 | $ | 1,185.1 | ||||||
Operating income before interest expense, other non-operating expense (income) and taxes, as reported |
$ | 184.9 | $ | 173.1 | $ | 159.0 | ||||||
Operating margins, as reported |
13.7% | 15.1% | 13.4% | |||||||||
Non-GAAP adjustments: |
||||||||||||
Restructuring charges: |
||||||||||||
Severance and related costs |
$ | (0.4 | ) | $ | 1.4 | $ | 1.2 | |||||
Asset impairment and lease cancellation charges |
1.2 | - | - | |||||||||
Other items |
(0.6 | ) | - | - | ||||||||
Adjusted operating income (non-GAAP) |
$ | 185.1 | $ | 174.5 | $ | 160.2 | ||||||
Adjusted operating margins (non-GAAP) |
13.8% | 15.2% | 13.5% | |||||||||
Depreciation and amortization |
$ | 28.8 | $ | 26.0 | $ | 24.3 | ||||||
Adjusted EBITDA (non-GAAP) |
$ | 213.9 | $ | 200.5 | $ | 184.5 | ||||||
Adjusted EBITDA margins (non-GAAP) |
15.9% | 17.5% | 15.6% | |||||||||
Retail Branding and Information Solutions | 3Q21 | 3Q20 | 3Q19 | |||||||||
Net sales |
$ | 530.7 | $ | 426.1 | $ | 406.8 | ||||||
Operating income before interest expense, other non-operating expense (income) and taxes, as reported |
$ | 58.5 | $ | 47.0 | $ | 45.7 | ||||||
Operating margins, as reported |
11.0% | 11.0% | 11.2% | |||||||||
Non-GAAP adjustments: |
||||||||||||
Restructuring charges: |
||||||||||||
Severance and related costs |
$ | 0.7 | $ | 2.2 | $ | 1.2 | ||||||
Asset impairment and lease cancellation charges |
0.1 | 0.7 | - | |||||||||
Other items |
13.8 | 1.5 | - | |||||||||
Adjusted operating income (non-GAAP) |
$ | 73.1 | $ | 51.4 | $ | 46.9 | ||||||
Adjusted operating margins (non-GAAP) |
13.8% | 12.1% | 11.5% | |||||||||
Depreciation and amortization |
$ | 26.3 | $ | 19.0 | $ | 13.3 | ||||||
Adjusted EBITDA (non-GAAP) |
$ | 99.4 | $ | 70.4 | $ | 60.2 | ||||||
Adjusted EBITDA margins (non-GAAP) |
18.7% | 16.5% | 14.8% | |||||||||
Industrial and Healthcare Materials | 3Q21 | 3Q20 | 3Q19 | |||||||||
Net sales |
$ | 195.3 | $ | 157.6 | $ | 169.5 | ||||||
Operating income before interest expense, other non-operating expense (income) and taxes, as reported |
$ | 18.7 | $ | 12.5 | $ | 17.7 | ||||||
Operating margins, as reported |
9.6% | 7.9% | 10.4% | |||||||||
Non-GAAP adjustments: |
||||||||||||
Restructuring charges: |
||||||||||||
Severance and related costs |
$ | 0.3 | $ | 2.9 | $ | 0.9 | ||||||
Asset impairment charges |
- | 3.7 | - | |||||||||
Other items |
0.4 | - | - | |||||||||
Adjusted operating income (non-GAAP) |
$ | 19.4 | $ | 19.1 | $ | 18.6 | ||||||
Adjusted operating margins (non-GAAP) |
9.9% | 12.1% | 11.0% | |||||||||
Depreciation and amortization |
$ | 6.8 | $ | 7.0 | $ | 6.4 | ||||||
Adjusted EBITDA (non-GAAP) |
$ | 26.2 | $ | 26.1 | $ | 25.0 | ||||||
Adjusted EBITDA margins (non-GAAP) |
13.4% | 16.6% | 14.7% | |||||||||
Corporate expense | 3Q21 | 3Q20 | 3Q19 | |||||||||
Corporate expense, as reported |
$ | (20.6 | ) | $ | (19.1 | ) | $ | (22.7 | ) | |||
Non-GAAP adjustments: |
||||||||||||
Restructuring charges: |
||||||||||||
Severance and related costs |
$ | 0.5 | $ | - | $ | - | ||||||
Other items |
- | - | 3.4 | |||||||||
Corporate expense (non-GAAP) |
$ | (20.1 | ) | $ | (19.1 | ) | $ | (19.3 | ) | |||
Total Company | 3Q21 | 3Q20 | 3Q19 | |||||||||
Net sales |
$ | 2,071.8 | $ | 1,729.1 | $ | 1,761.4 | ||||||
Operating income before interest expense, other non-operating expense (income) and taxes, as reported |
$ | 241.5 | $ | 213.5 | $ | 199.7 | ||||||
Operating margins, as reported |
11.7% | 12.3% | 11.3% | |||||||||
Non-GAAP adjustments: |
||||||||||||
Restructuring charges: |
||||||||||||
Severance and related costs |
$ | 1.1 | $ | 6.5 | $ | 3.3 | ||||||
Asset impairment and lease cancellation charges |
1.3 | 4.4 | - | |||||||||
Other items |
13.6 | 1.5 | 3.4 | |||||||||
Adjusted operating income (non-GAAP) |
$ | 257.5 | $ | 225.9 | $ | 206.4 | ||||||
Adjusted operating margins (non-GAAP) |
12.4% | 13.1% | 11.7% | |||||||||
Depreciation and amortization |
$ | 61.9 | $ | 52.0 | $ | 44.0 | ||||||
Adjusted EBITDA (non-GAAP) |
$ | 319.4 | $ | 277.9 | $ | 250.4 | ||||||
Adjusted EBITDA margins (non-GAAP) |
15.4% | 16.1% | 14.2% |
-more-
A-9
AVERY DENNISON CORPORATION
PRELIMINARY SUPPLEMENTARY INFORMATION
Reconciliation of Adjusted EBITDA Margins and Net Debt to Adjusted EBITDA
(In millions, except %)
(UNAUDITED)
(14 weeks) | (13 weeks) | (13 weeks) | (13 weeks) | |||||||||||||
QTD | ||||||||||||||||
Total Company | 4Q20 | 1Q21 | 2Q21 | 3Q21 | ||||||||||||
Net sales |
$ | 1,990.9 | $ | 2,051.3 | $ | 2,102.0 | $ | 2,071.8 | ||||||||
Operating income before interest expense, other non-operating expense (income) and taxes, as reported |
$ | 273.0 | $ | 283.8 | $ | 269.9 | $ | 241.5 | ||||||||
Operating margins, as reported |
13.7% | 13.8% | 12.8% | 11.7% | ||||||||||||
Non-GAAP adjustments: |
||||||||||||||||
Restructuring charges: |
||||||||||||||||
Severance and related costs |
$ | 2.7 | $ | 2.4 | $ | 1.6 | $ | 1.1 | ||||||||
Asset impairment and lease cancellation charges |
- | 0.5 | 0.1 | 1.3 | ||||||||||||
Other items |
(6.4 | ) | (2.0 | ) | (2.3 | ) | 13.6 | |||||||||
Adjusted operating income (non-GAAP) |
$ | 269.3 | $ | 284.7 | $ | 269.3 | $ | 257.5 | ||||||||
Adjusted operating margins (non-GAAP) |
13.5% | 13.9% | 12.8% | 12.4% | ||||||||||||
Depreciation and amortization |
$ | 55.5 | $ | 54.4 | $ | 55.2 | $ | 61.9 | ||||||||
Adjusted EBITDA (non-GAAP) |
$ | 324.8 | $ | 339.1 | $ | 324.5 | $ | 319.4 | ||||||||
Adjusted EBITDA margins (non-GAAP) |
16.3% | 16.5% | 15.4% | 15.4% | ||||||||||||
|
||||||||||||||||
Total Debt |
$ | 3,199.0 | ||||||||||||||
Less: Cash and cash equivalents |
207.2 | |||||||||||||||
Net Debt |
$ | 2,991.8 | ||||||||||||||
Net Debt to Adjusted EBITDA
LTM* |
2.3 | |||||||||||||||
*LTM = Last twelve months (4Q20 to 3Q21)
-more-
A-10
AVERY DENNISON CORPORATION
PRELIMINARY SUPPLEMENTARY INFORMATION
(UNAUDITED)
Third Quarter 2021 (vs. 2020) | ||||||||||||||||
Total Company |
Label and Graphic |
Retail Information Solutions |
Industrial and Healthcare Materials |
|||||||||||||
Reconciliation from GAAP to Non-GAAP sales change |
||||||||||||||||
Reported net sales change |
19.8% | 17.5% | 24.5% | 23.9% | ||||||||||||
Foreign currency translation |
(2.8%) | (2.9%) | (2.4%) | (4.0%) | ||||||||||||
Extra week impact |
--- | --- | --- | --- | ||||||||||||
Sales change ex. currency (non-GAAP)(1) |
17.0% | 14.6% | 22.2% | 20.0% | ||||||||||||
Acquisitions and product line divestitures |
(3.0%) | (0.6%) | (8.8%) | (5.1%) | ||||||||||||
Organic sales change (non-GAAP)(1) |
13.9% | 14.0% | 13.5% | 14.9% | ||||||||||||
Third Quarter 2021 (vs. 2019)(2) | ||||||||||||||||
Total Company |
Label and Graphic |
Retail Branding and Information |
Industrial and Healthcare Materials |
|||||||||||||
Reconciliation from GAAP to Non-GAAP sales change |
||||||||||||||||
Reported net sales change |
17.6% | 13.6% | 30.5% | 15.2% | ||||||||||||
Foreign currency translation |
(2.0%) | (1.9%) | (1.3%) | (4.1%) | ||||||||||||
Extra week impact |
--- | --- | --- | --- | ||||||||||||
Sales change ex. currency (non-GAAP)(1) |
15.6% | 11.6% | 29.2% | 11.0% | ||||||||||||
Acquisitions and product line divestitures |
(5.4%) | (0.4%) | (20.5%) | (4.7%) | ||||||||||||
Organic sales change (non-GAAP)(1) |
10.1% | 11.2% | 8.7% | 6.4% | ||||||||||||
Nine Months Ended 2021 (vs. 2020) | ||||||||||||||||
Total Company |
Label and Graphic Materials |
Retail Branding and Information Solutions |
Industrial and Healthcare Materials |
|||||||||||||
Reconciliation from GAAP to Non-GAAP sales change |
||||||||||||||||
Reported net sales change |
25.0% | 19.8% | 37.4% | 33.4% | ||||||||||||
Foreign currency translation |
(5.0%) | (5.3%) | (3.1%) | (6.4%) | ||||||||||||
Extra week impact |
(1.4%) | (1.4%) | (1.4%) | (1.6%) | ||||||||||||
Sales change ex. currency (non-GAAP)(1) |
18.6% | 13.1% | 32.9% | 25.4% | ||||||||||||
Acquisitions and product line divestitures |
(2.1%) | (0.7%) | (5.4%) | (4.6%) | ||||||||||||
Organic sales change (non-GAAP)(1) |
16.5% | 12.4% | 27.5% | 20.9% |
(1) Totals may not sum due to rounding.
(2) Third quarter 2021 vs. 2019 results are presented to facilitate comparison with pre-pandemic performance.
Third Quarter 2021 Financial Review and Analysis (preliminary, unaudited) October 27, 2021 Supplemental Presentation Materials Unless otherwise indicated, comparisons are to the same period in the prior year. Exhibit 99.2
Safe Harbor Statement Certain statements contained in this document are "forward-looking statements" intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements, and financial or other business targets, are subject to certain risks and uncertainties. Forward-looking statements also include those related to the acquisition of Vestcom, including its anticipated benefits, financing and effect on our long-term targets and future financial results. We believe that the most significant risk factors that could affect our financial performance in the near-term include: (i) the impacts to underlying demand for our products and/or foreign currency fluctuations from global economic conditions, political uncertainty, changes in environmental standards and governmental regulations, including as a result of COVID-19; (ii) competitors’ actions, including pricing, expansion in key markets, and product offerings; (iii) the degree to which higher costs can be offset with productivity measures and/or passed on to customers through price increases, without a significant loss of volume; and (iv) the execution and integration of acquisitions, including the acquisition of Vestcom. Actual results and trends may differ materially from historical or anticipated results depending on a variety of factors, including but are not limited to, risks and uncertainties relating to the following: COVID-19 International Operations – worldwide and local economic and market conditions; changes in political conditions; and fluctuations in foreign currency exchange rates and other risks associated with foreign operations, including in emerging markets Our Business – changes in our markets due to competitive conditions, technological developments, environmental standards, laws and regulations, and customer preferences; fluctuations in demand affecting sales to customers; execution and integration of acquisitions, including the acquisition of Vestcom; selling prices; fluctuations in the cost and availability of raw materials and energy; the impact of competitive products and pricing; customer and supplier concentrations or consolidations; financial condition of distributors; outsourced manufacturers; product and service quality; timely development and market acceptance of new products, including sustainable or sustainably-sourced products; investment in development activities and new production facilities; successful implementation of new manufacturing technologies and installation of manufacturing equipment; our ability to generate sustained productivity improvement; our ability to achieve and sustain targeted cost reductions; and collection of receivables from customers Vestcom acquisition – significant transaction costs or unknown or inestimable liabilities; risks related to future opportunities and plans for the combined company, including the uncertainty of expected future financial performance and results of the combined company; and the possibility that, if we do not achieve the perceived benefits of the acquisition as rapidly or to the extent anticipated by financial analysts or investors, the market price of our common stock could decline Income Taxes – fluctuations in tax rates; changes in tax laws and regulations, and uncertainties associated with interpretations of such laws and regulations; retention of tax incentives; outcome of tax audits; and the realization of deferred tax assets Information Technology – disruptions in information technology systems, including cyber-attacks or other intrusions to network security; successful installation of new or upgraded information technology systems; and data security breaches Human Capital – recruitment and retention of employees; fluctuations in employee benefit costs; and collective labor arrangements Our Indebtedness – credit risks; our ability to obtain adequate financing arrangements and maintain access to capital; volatility of financial markets; fluctuations in interest rates; and compliance with our debt covenants Ownership of Our Stock – potential significant variability of our stock price and amounts of future dividends and share repurchases Legal and Regulatory Matters – protection and infringement of intellectual property and impact of legal and regulatory proceedings, including with respect to environmental, health and safety, anti-corruption and trade compliance Other Financial Matters – fluctuations in pension costs and goodwill impairment For a more detailed discussion of these factors, see “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our 2020 Form 10-K, filed with the Securities and Exchange Commission on February 25, 2021, and subsequent quarterly reports on Form 10-Q. The forward-looking statements included in this document are made only as of the date of this document, and we undertake no obligation to update these statements to reflect subsequent events or circumstances, other than as may be required by law.
Use of Non-GAAP Financial Measures This presentation contains certain non-GAAP financial measures as defined by SEC rules. We report our financial results in conformity with accounting principles generally accepted in the United States of America, or GAAP, and also communicate with investors using certain non-GAAP financial measures. These non-GAAP financial measures are not in accordance with, nor are they a substitute for or superior to, the comparable GAAP financial measures. These non-GAAP financial measures are intended to supplement the presentation of our financial results that are prepared in accordance with GAAP. Based upon feedback from investors and financial analysts, we believe that the supplemental non-GAAP financial measures we provide are useful to their assessments of our performance and operating trends, as well as liquidity. In accordance with Regulations G and S-K, reconciliations of non-GAAP financial measures to the most directly comparable GAAP financial measures, including limitations associated with these non-GAAP financial measures, are provided in the financial schedules accompanying the earnings news release for the quarter (see Attachments A-4 through A-10 to news release dated October 27, 2021). Our non-GAAP financial measures exclude the impact of certain events, activities or strategic decisions. The accounting effects of these events, activities or decisions, which are included in the GAAP financial measures, may make it difficult to assess our underlying performance in a single period. By excluding the accounting effects, positive or negative, of certain items (e.g., restructuring charges, outcomes of certain legal proceedings, certain effects of strategic transactions and related costs, losses from debt extinguishments, gains or losses from curtailment or settlement of pension obligations, gains or losses on sales of certain assets, gains or losses on investments, and other items), we believe that we are providing meaningful supplemental information that facilitates an understanding of our core operating results and liquidity measures. While some of the items we exclude from GAAP financial measures recur, they tend to be disparate in amount, frequency, or timing. We use these non-GAAP financial measures internally to evaluate trends in our underlying performance, as well as to facilitate comparison to the results of competitors for quarters and year-to-date periods, as applicable. We use the non-GAAP financial measures described below in the accompanying news release and presentation. • Sales change ex. currency refers to the increase or decrease in net sales, excluding the estimated impact of foreign currency translation, and, where applicable, the calendar shift resulting from the extra week in the prior fiscal year and currency adjustment for transitional reporting of highly inflationary economies. The estimated impact of foreign currency translation is calculated on a constant currency basis, with prior period results translated at current period average exchange rates to exclude the effect of currency fluctuations. • Organic sales change refers to sales change ex. currency, excluding the estimated impact of acquisitions and product line divestitures. We believe that sales change ex. currency and organic sales change assist investors in evaluating the sales change from the ongoing activities of our businesses and enhance their ability to evaluate our results from period to period. • Adjusted operating income refers to income before taxes; interest expense; other non-operating expense (income), net; and other expense (income), net. • Adjusted EBITDA refers to adjusted operating income before depreciation and amortization. • Adjusted operating margin refers to adjusted operating income as a percentage of net sales. • Adjusted EBITDA margin refers to adjusted EBITDA as a percentage of net sales. • Adjusted tax rate refers to the projected full-year GAAP tax rate, adjusted to exclude certain unusual or infrequent events that are expected to significantly impact that rate, such as effects of certain discrete tax planning actions, impacts related to the enactment of the U.S. Tax Cuts and Jobs Act ("TCJA"), where applicable, and other items. • Adjusted net income refers to income before taxes, tax-effected at the adjusted tax rate, and adjusted for tax-effected restructuring charges and other items. • Adjusted net income per common share, assuming dilution (adjusted EPS) refers to adjusted net income divided by weighted average number of common shares outstanding, assuming dilution. We believe that adjusted operating margin, adjusted EBITDA margin, adjusted net income, and adjusted EPS assist investors in understanding our core operating trends and comparing our results with those of our competitors. • Net debt to adjusted EBITDA ratio refers to total debt (including finance leases) less cash and cash equivalents, divided by adjusted EBITDA for the last twelve months. We believe that the net debt to adjusted EBITDA ratio assists investors in assessing our leverage position. • Free cash flow refers to cash flow provided by operating activities, less payments for property, plant and equipment, software and other deferred charges, plus proceeds from sales of property, plant and equipment, plus (minus) net proceeds from insurance and sales (purchases) of investments. Free cash flow is also adjusted for, where applicable, certain acquisition-related transaction costs. We believe that free cash flow assists investors by showing the amount of cash we have available for debt reductions, dividends, share repurchases, and acquisitions. This document has been furnished (not filed) on Form 8-K with the SEC and may be found on our website at www.investors.averydennison.com
Third Quarter 2021 Review Continued to deliver strong results amidst dynamic supply environment Vestcom acquisition closed in Q3; modest EPS accretion expected for FY21 Reported sales increased 20% Sales growth ex. currency (non-GAAP) of 17%; organic sales growth (non-GAAP) of 14% Compared to 2019, sales growth ex. currency of 16%; organic sales growth of 10% Strong volume growth in addition to the impact of higher prices Reported operating margin of 11.7%, down 60 bps Adj. EBITDA margin (non-GAAP) of 15.4%, down 70 bps vs. 2020 (up 120 bps vs. 2019) Strong performance despite supply chain disruptions and impacts of price increases and inflationary pressures Reported EPS of $1.96, up 9%; adj. EPS (non-GAAP) of $2.14, up 12% vs. 2020 (up 29% vs. 2019) YTD free cash flow (non-GAAP) of $639 mil., up $298 mil. FY21 adj. EPS guidance raised to $8.80 to $8.95; midpoint up 25% vs. 2020 and 34% vs. 2019 Organic sales growth outlook at high end of previous range ~15% Now expecting sequential inflation in Q4; price increases underway with customary ~3 month lag
Operational/Market Update As pandemic evolves, continue to adapt world-class safety protocols Safety and well-being of employees remains our top priority Parts of the world, particularly South Asia, experienced a surge in COVID-19 cases in Q3 RBIS Vietnam in particular was significantly constrained for the majority of Q3 All manufacturing locations now largely operational Continue to actively manage dynamic supply and demand environment Demand across majority of businesses/regions remains very strong Raw materials, freight and labor availability (particularly in the U.S.) continue to be constrained Lead times remain elevated given demand and supply imbalance Continuing to leverage our global scale, working closely with customers/suppliers to minimize disruptions Inflation remains persistent in the materials businesses, with further sequential inflation in Q4 Anticipate ~10% inflation for FY21; up nearly 20% in Q4 (~$600 mil. annualized inflation) Additional pricing and material re-engineering actions being implemented Team continues to demonstrate agility and leverage scenario planning to deliver for all stakeholders
Quarterly Sales Trend Analysis 1Q20 2Q20 3Q20 4Q20 1Q21 2Q21 3Q21 Reported Sales Change (1.0%) (14.9%) (1.8%) 12.3% 19.1% 37.5% 19.8% Organic Sales Change 0.3% (13.7%) (3.6%) 3.2% 8.8% 28.1% 13.9% Acquisitions/Divestitures 0.7% 1.7% 2.3% 2.0% 2.1% 1.1% 3.0% Sales Change Ex. Currency* 1.0% (12.0%) (1.3%) 5.2% 10.9% 29.2% 17.0% Extra Week Impact - - - 4.9% 3.8% - - Currency Translation (1.9%) (2.9%) (0.5%) 2.3% 4.4% 8.3% 2.8% Reported Sales Change* (1.0%) (14.9%) (1.8%) 12.3% 19.1% 37.5% 19.8% *Totals may not sum due to rounding.
Organic Sales Change 1Q20 2Q20 3Q20 4Q20 1Q21 2Q21 3Q21 LGM 2% (5%) (3%) 4% 8% 16% 14% LPM 3% 0% (2%) 5% 7% 12% 15% Graphics & Reflective (5%) (31%) (8%) (5%) 9% 49% 11% RBIS* (1%) (36%) (5%) 3% 9% 72% 14% IHM (8%) (21%) (8%) 1% 16% 33% 15% Total Company 0% (14%) (4%) 3% 9% 28% 14% Total Company Sales Change Ex. Currency 1% (12%) (1%) 5% 11% 29% 17% Quarterly Sales Trend Analysis (cont.) * Q3 2021 Intelligent Labels sales up ~15% on organic basis compared to prior year (up ~40% vs. 2019)
Third Quarter Sales Growth and Operating Margin Comparison Operating Margin Reported Operating Margin Adj. (Non-GAAP) EBITDA Margin Adj. (Non-GAAP) 3Q21 3Q20 3Q19 3Q21 3Q20 3Q19 3Q21 3Q20 3Q19 Label and Graphic Materials 13.7% 15.1% 13.4% 13.8% 15.2% 13.5% 15.9% 17.5% 15.6% Retail Branding and Information Solutions 11.0% 11.0% 11.2% 13.8% 12.1% 11.5% 18.7% 16.5% 14.8% Industrial and Healthcare Materials 9.6% 7.9% 10.4% 9.9% 12.1% 11.0% 13.4% 16.6% 14.7% Total Company 11.7% 12.3% 11.3% 12.4% 13.1% 11.7% 15.4% 16.1% 14.2% Third Quarter Sales Growth Reported Ex. Currency (‘21 vs. ‘20) Ex. Currency (‘21 vs. ‘19) Organic (‘21 vs. ‘20) Organic (‘21 vs. ‘19) Label and Graphic Materials 17.5% 14.6% 11.6% 14.0% 11.2% Retail Branding and Information Solutions 24.5% 22.2% 29.2% 13.5% 8.7% Industrial and Healthcare Materials 23.9% 20.0% 11.0% 14.9% 6.4% Total Company 19.8% 17.0% 15.6% 13.9% 10.1%
Label and Graphic Materials Reported sales increased 18% to $1.3 bil. Sales were up 15% ex. currency (up 12% vs. 2019) and 14% organically (up 11% vs. 2019) Label and Packaging Materials up ~15% organically, with strong growth in both the high value product categories and the base business Combined Graphics and Reflective Solutions up ~11% organically Organically, North America and emerging markets both up low double digits and Western Europe up more than 20% Reported operating margin decreased 140 bps to 13.7% Adjusted operating margin decreased 140 bps to 13.8% as the benefit of higher volume/mix, net of supply chain disruptions, was more than offset by the net impact of pricing and raw material costs and higher employee-related costs The higher revenue base from price increases alone, with no corresponding incremental operating income as they are offsetting inflation, reduced margin by ~75 bps in the third quarter 2020 Sales by Product Base (Label & Graphics) Specialty/Durables Labels Specialty Graphics Reflectives 2020 Sales by Geography U.S. & Canada Western Europe E. Europe & MENA Asia Pacific Latin America High Value Categories ~32% Emerging Markets ~40% Third Quarter 2021 Results End Market Product Category
Retail Branding and Information Solutions Reported sales increased 25% to $531 mil. Sales were up 22% ex. currency (up 29% vs. 2019) and 14% organically (up 9% vs. 2019) Strong growth in both the high value product categories and the base business Intelligent Labels up ~15% organically (up ~40% vs. 2019) Reported operating margin flat to prior year at 11.0% Adjusted operating margin increased 170 bps to 13.8% as the benefits from higher volume and productivity were partially offset by the headwind from prior year temporary cost reduction actions, higher employee-related costs and growth investments Vestcom acquisition closed in Q3 Expands RBIS’ role managing variable data in adjacent markets Accelerates portfolio shift to high value categories Above average sales growth and margin profile Modest EPS accretion expected FY21 2020 Sales by Product Base Tags & Labels Intelligent Labels Ext. Embellishments AIDC(1) Solutions Third Quarter 2021 Results 2020 Sales by Geography U.S. & Canada Europe Asia Pacific Latin America Estimated End Market Product Category High Value Categories ~37% (1) Automatic Identification and Data Capture (“AIDC”)
Industrial and Healthcare Materials Reported sales increased 24% to $195 mil. Sales were up 20% ex. currency (up 11% vs. 2019) and 15% organically (up 6% vs. 2019) Industrial categories up high-teens Healthcare up high-single digits Reported operating margin increased 170 bps to 9.6% Adjusted operating margin decreased 220 bps to 9.9% as the benefit from higher volume/mix, net of supply chain disruptions, was more than offset by the net impact of pricing, freight and raw material costs and higher employee-related costs 2020 Sales by Product Automotive Other Industrial Healthcare Retail 2020 Sales by Geography U.S. & Canada Europe Asia Pacific Latin America Third Quarter 2021 Results High Value Categories ~74% Estimated End Market Product Category
2021 EPS Guidance Add Back: Est. restructuring costs and other items Adjusted EPS (non-GAAP) Reported EPS $8.55 – $8.70 $8.80 – $8.95 Contributing Factors to 2021 Results Reported sales growth of ~20%; ~3.5% currency tailwind; ~1.5% extra week impact headwind Ex. currency growth of ~18% (previously 14% to 16%); ~3% benefit from M&A Organic sales growth of ~15% (previously 13% to 15%) FY headwind of ~$0.15 from calendar shift (Q1 tailwind of ~$0.15, Q4 headwind of ~$0.30) Currency translation benefit to operating income of ~$30 mil. (previously ~$35 mil.) Incremental savings of ~$60 mil. from restructuring actions, net of transition costs Pace of investment expected to accelerate throughout the year Tax rate in mid-twenty percent range Avg. shares outstanding (assuming dilution) of ~83.5 mil. Free cash flow of $700+ mil. ~$0.25 Previous Updated $8.50 – $8.80 $8.65 – $8.95 ~$0.15
Thank you